Date: 2011-04-05
Type of information: Collaboration agreement
Compound: IT Omics tools
Company: Integromics (Spain) Ingenuity Systems (USA)
Therapeutic area:
Type agreement: collaboration licensing
Action mechanism:
Disease:
Details: The provider of IT solutions for life sciences in the field of genomics and proteomics, Integromics has extended its partnership with Ingenuity(R), a provider of information and analytics solutions for life science researchers. The partnership extension involves the scheduled integration of Integromics’ fourth product, SeqSolve™ to offer the most complete collection of Omics tools integrated with Ingenuity’s IPA® software. The SeqSolve analysis software, exclusively designed for Next Generation Sequencing (NGS), performs tertiary level analysis of RNA-seq data at the gene and transcript level for biologically relevant results. Integromics has already integrated three solutions with Ingenuity’s IPA: Integromics Biomarker Discovery® for microarray data analysis, RealTime StatMiner(R) for the analysis of qPCR data as well as OmicsHub® Proteomics for the analysis and storage of proteomics data. The combined solutions will enable users to go from the aligned sequences to the function, interactions, pathways and disease association of the genes or variant forms identified in the experiment. Ingenuity gains access to the NGS and proteomics domains as well as a powerful suite of genomics tools and a proteomics tool tightly integrated with their pathway tool.
Financial terms:
Latest news:
